Sept 8 (Reuters) - Recce Pharmaceuticals Ltd RCE.AX :
* POSITIVE & CONCENTRATION-DEPENDENT EFFICACY OF RECCE COMPOUNDS AGAINST COVID-19 IN INTERNATIONAL STUDY
* ADVANCING TO ANIMAL IN-VIVO COVID-19 STUDIES
* CO'S COMPOUNDS HAVE SHOWN CONCENTRATION-DEPENDENT REDUCTIONS IN COVID-19 IN AN IN-VITRO STUDY